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Research article 
Overexpression of G6PDH does not affect the behavior of HEK-293 
clones stably expressing interferon-α2b 
Edwige Arnold 1, Iness Hammami 1, Jingkui Chen 1, Sachin Gupte 2, Yves Durocher 3, and 
Mario Jolicoeur 1,* 
1 Research Laboratory in Applied Metabolic Engineering, Department of Chemical Engineering, 
École Polytechnique de Montréal, Montréal, Québec, Canada 
2 Department of Pharmacology, New York Medical College, Valhalla, NY 10595 
3 National Research Council, Montréal, Québec, Canada 
* Correspondence: Email: mario.jolicoeur@polymtl.ca; Tel: +1-514-340-4711 ext. 4525;  
Fax: +1-514-340-4159. 
Abstract: HEK293 cells are gaining in interest for the production of recombinant proteins. However, 
further understanding and engineering of cell metabolism are still needed to improve protein titers. 
The importance of G6PDH has already been studied regarding redox balance, and a correlation has 
recently been established between the oxidative pentose phosphate pathway (PPP) and antibody peak 
production. In this work, HEK293 cells stably expressing interferon-α2b, a parental clone, and a 
further engineered clone expressing the cytosolic yeast pyruvate-carboxylase (PYC) were transiently 
transfected to overexpress glucose-6-phosphate dehydrogenase (G6PDH) and increase fluxes 
through the PPP. The aim of the study was thus to evaluate the effect of overexpressing G6PDH on 
the “pull” effect brought by the PYC phenotype. Results indicate that the cell metabolism is, 
however, highly robust, showing a highly regulated PPP damping the potential effects of 
overexpressing G6PDH. A metabolomic study also clearly demonstrates, by metabolites profiling, 
that the PYC clone has a highly robust and more efficient metabolic efficiency, compared to its 
parental clone. 
Keywords: G6PDH overexpression; Pentose Phosphate Pathway; HEK-293; metabolomics; cell 
energetics; Pyruvate Carboxylase 
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Abbreviations 
ADP  Adenosine diphosphate 
Ala  Alanine 
AMP  Adenosine monophosphate 
ATP  Adenosine triphosphate 
Asn  Asparagine  
Asp  Aspartate  
Arg  Arginine 
CTP  Cytidine triphosphate 
DHAP  Dihydroxyacetone phosphate 
DsRed  A red fluorescent protein originally obtained from Discosoma sp. 
FAD  Flavine adénine dinucléotide 
G6P  Glucose-6-phosphate 
GA3P  Glyceraldehyde-3-phosphate 
Glu  Glutamate  
Gln  Glutamine  
Gly  Glycine 
Gly3P  Glycerol-3-phosphate 
GTP  Guanosine triphosphate 
HEK-293 Human embryonic kidney cell line 293 
Ile  Isoleucine 
Leu  Leucine 
Met  Methionine 
NAD+  Nicotinamide adenine dinucleotide, oxidizing agent 
NADH Nicotinamide adenine dinucleotide, reducing agent 
NADP+ Nicotinamide adenine dinucleotide phosphate, oxidizing agent  
NADPH Nicotinamide adenine dinucleotide phosphate, reducing agent  
Phe  Phenylalanine 
Pro  Proline 
PYC  Pyruvate carboxylase 
Thr  Threonine 
Tyr  Tyrosine 
UDPG  Uridine diphosphate glucose 
UTP  Uridine triophosphate 
Val  Valine 
 
1. Introduction 
The mammalian cell platform is now seen as the workhorse of the recombinant protein industry 
because of its ability to perform proper protein folding and assembly, and post- translational 
modifications. Even if CHO cell lines appear to be the preferred hosts, HEK293 cells are gaining in 
interest for the production of recombinant proteins. Firstly used for the production of various viral 
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vectors [1,2], their attractiveness lies in their human origin, a high transfectability and their capacity 
to grow in serum-free media in suspension [2,3]. Loignon et al. [4–6] have recently described the 
establishment of an IFN-α2b stably-expressing HEK293 clone (D9) and of its further improved 
pyruvate carboxylase (PYC) expressing clone (F5), which showed to allow an increase of the 
maximum cell density, and a decrease of lactate and ammonia production in batch culture, thus 
decreasing the secretion of toxic metabolic by-products [7–9]. This phenotype was successfully 
exploited by Vallée et al. [10] through a fed-batch culture strategy leading to an increase of the 
maximum cell density up to 107 cells/mL and a 4-fold increase of the yield in interferon, compared to 
a batch culture of the parental clone. These achievements clearly showed the benefit of “pulling” on 
the metabolism bypassing a well- controlled entry point to the Krebs’ cycle (TCA), as showed by a 
13C MFA (Metabolic Flux Analysis) study [4]. This work also reveals, however, the need of 
combining a coherent set of metabolic engineering works to succeed redirecting carbon flow 
maximizing the cell specific productivity without affecting cell growth rate, since the HEK293 PYC 
clone showed similar cell specific productivity in interferon. It is well known that the production of 
recombinant proteins results in a metabolic burden and is energetically costly with three ATP 
molecules required for the synthesis of one peptide bond [11,12]. This high energetic demand is not 
only related to the synthesis of the building blocks for protein synthesis and translation and 
transcription, such as amino acids and nucleotides, but also at all stages including protein folding [7]. 
The use of metabolic flux analysis (MFA) and 13C labeling recently showed that the peak 
antibody production occurs at late exponential and stationary phases, and is associated with elevated 
oxidative pentose phosphate pathway (PPP) activity and high NADPH production rate [12–14]. In 
the contrary, the peak cell growth rate is observed at mid-exponential phase and is characterized by a 
high glycolytic rate. Dean and Reddy [15] have hypothesized that high producer clones may be 
characterized by a highly active oxidative metabolism. Indeed, products of PPP include ribose-5-
phosphate and erythrose-4-phosphate, which are involved in nucleotides and amino acids synthesis, 
and NADPH as a reducing agent. In previous works, we showed that the oxidative PPP was more 
active in CHO cell cultures performed at low-density with a higher specific production and growth 
rate compared to high-density cell cultures [16]. Furthermore, strategies aiming at redirecting the 
carbon flux through PPP have already been proven successful in bacteria and yeasts through G6PDH 
overexpression or combined with other enzymes [17–20], since NADPH is mostly synthesized via 
PPP by the G6PDH enzyme and to a lesser extent by 6PGD, malic enzyme and isocitrate 
dehydrogenase [21–24]. In addition and of interest, G6PDH is thought being necessary to counter the 
damages caused by reactive oxygen species (ROS) and restore the redox balance [22,25–28], such as 
a stressful metabolic load from recombinant protein processing. 
In this work, we have investigated the effect of enhancing the rate of entry of G6P into PPP, 
thus bypassing the highly regulated glycolysis upstream [29], on the production yield and maximum 
cell density in HEK-293 cells. We have overexpressed the G6PDH gene level by transient 
transfection of HEK293 D9 and F5 clones in batch cultures, therefore exploiting the “pulling” effect 
of the PYC cells. The analysis of G6PDH activity and of the cell metabolome revealed a high cell 
metabolic robustness and a high PPP regulation level. 
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2. Material and Methods 
2.1. Cell lines 
The parental cell line HEK293-D9, stably expressing interferon-α2b, is derived from the HEK-
6E cell line constitutively expressing the EBNA1 protein from the Epstein-Barr virus [6]. The 
HEK293-F5 clone was generated from the parental cell line by transfection of the cytoplasmic yeast 
pyruvate carboxylase 2 gene (PYC) [5] (Gene ID: 852519) as described by Henry and Durocher [4]. 
2.2. Cell culture 
Before culturing the cells, fresh Freestyle F17 expression medium (Invitrogen Life Technology, 
USA) was supplemented with 4 mM glutamine (Sigma-Aldrich, USA) and 0.1% (w/v) Kolliphor 
P188 (Sigma-Aldrich). Cells were inoculated at 0.2 × 106 cells/mL in 125 mL shake-flasks (VWR, 
Canada) and grown in suspension at 37 °C under 5% CO2 on an orbital shaker at 120 RPM. Batch 
experiments were carried out in duplicate at a 20 mL initial working volume. Cells (except negative 
control) were transfected at a 2 × 106 cells/mL density. Cultures were harvested each day and 
supernatants were collected by centrifugation at 300 g for 5 min. Samples were stored at − 20°C for 
subsequent analyses. 
2.3. Plasmids and cell transfection 
Empty plasmid pDsRed-Monomer-N1 was obtained from Clontech Laboratories (USA) and 
was used as a control to assess the impact of transfection. The modified pDsRed1-N1 vector used to 
overexpress G6PDH was provided by Dr. Gupte [30]. Because of commercial unavailability, the two 
plasmids differ in that they have not the same fluorescent protein. The pDsRed-Monomer-N1 
plasmid codes for the monomeric DsRed protein (max. excitation/emission at 557/592 nm) and the 
pDsRed1-N1 vector codes for the original DsRed protein (558/583 nm). DsRed is fused with 
G6PDH, thus allowing the direct screening of the secreted molecule. It has been reported that the 
DsRed from pDsRed-N1 is only fluorescent as oligomers [31]. 25 kDa linear polyethylenimine (PEI) 
was obtained from Sigma-Aldrich. The PEI solution was prepared as reported by Tom et al. [32]. 
DNA and PEI were incubated in 10% of the final volume in culture medium without Kolliphor for 
10 min at room temperature and then added to cultures. Final DNA concentration in the media was 
set at 1 µg/mL. Early tests were performed to assess PEI/DNA ratios (data not shown) and a 2:1 
PEI:DNA ratio was found to be optimal. Transfection efficiency was screened using a fluorescence 
microscope (ZEISS Observer.Z1). 
2.4. Metabolites extraction 
3 × 106 cells were washed with cold PBS and extracted with 400 µL of 80% cold methanol in 
the presence of 0.2 g of sand (Sigma-Aldrich). After 30 min on dry ice, the mixture was vortexed and 
sonicated in iced water bath for 5 min. The mixture was then centrifuged for 7 min at 21,000 g and 
4 °C to collect supernatants. Pellets were extracted a second time with 200 µL of 50% cold methanol 
and a third time with 200 µL of cold water as described above. Supernatants were mixed, filtered 
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through 0.2 µm PTFE filters (VWR) and stored at −80°C for subsequent analyses. 
2.5. Analytical methods 
Cell density and viability were assessed with a hemocytometer and a standard light microscope 
using the trypan blue exclusion method. High cell density samples were diluted in phosphate-buffer 
saline (Sigma-Aldrich) before mixing with the exclusion dye. Glucose, lactate, glutamine and 
glutamate concentrations were measured using a dual-channeled immobilized oxidase enzyme 
biochemistry analyzer (2700 SELECT, YSI Inc. Life Sciences, Yellow Springs, OH, USA) using 
calibration buffers provided by the manufacturer. Interferon-α titers were measured using a 
commercial enzyme-linked immunosorbent assay (ELISA), the Human IFN-α Platinium ELISA kit 
(eBioscience, USA) according to the manufacturer’s instructions. G6PDH activity assay was 
performed using Bertin Pharma’s kit (France, Cat. #D05010) according to manufacturer’s 
instructions. Nucleotides, organic acids, sugar phosphates and extracellular amino acids 
concentrations were assessed using an Agilent 1290 HPLC system (Agilent technologies, Quebec, 
Canada) as previously described by Ghorbaniaghdam et al. [33]. Ammonia extracellular 
concentrations were analyzed using an ammonia assay kit (K-AMIAR, Megazyme International 
Ireland Ltd). 
2.6. Western Blot analysis 
4 × 105 cells were first washed with cold PBS containing 1 mM sodium orthovanadate and then 
lysed in 100 µL of lysis buffer (50 mM HEPES of pH 7.4, 150 mM NaCl, 1% Thesit, 0.5% sodium 
deoxycholate, 1 mM sodium orthovanadate) for 20 min on ice [34]. Insoluble materials were 
removed by centrifugation at 10,000 g for 5 min. Samples were mixed 3:1 (v/v) in a buffer 
containing 25% glycerol, 0.011% bromophenol blue, 2% SDS, 5% β- mercaptoethanol and 62.5 mM 
Tris HCl, pH 6.8, and boiled for 5 min. Proteins were separated at 200 V for ~35 min using 10% 
acrylamide gels. Proteins were transferred to a PVDF membrane (Bio-Rad, USA) using Tris-glycine 
buffer for 1 h at 200 mA. The membrane was blocked with 5% skimmed milk in 10 mM Tris-HCl, 
pH 7.4, 150 mM NaCl, 0.1% Tween-20. Probing was done with a 1:1,000 diluted G6PD rabbit 
primary antibody (Cell Signaling, USA, Cat. #12263) incubated at 4°C overnight and specific 
binding was detected after rinse using a 1:1,000 diluted HRP-linked anti-rabbit IgG (Cell Signaling, 
Cat. #7074) incubated 1 h at room temperature. The visualization was performed using a 
chemiluminescence HRP detection kit (Immun-Star, Bio-Rad, USA). 
3. Results and Discussion 
3.1. Active G6PDH can be overexpressed in both HEH293 cell lines 
Transfection condition was first tested at 24 h, but showed to be highly detrimental to cell 
growth and viability (data not shown). Both cell lines were thus transiently transfected at late 
exponential phase, in order to maximize the potential effect on the cell oxidative state of 
overexpressing G6PDH. Transfections were thus performed at 67 h, while the cells are still within 
exponential phase with viabilities above 95%.  
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Figure 1. G6PDH overexpression in HEK-293 cells. (A) Fluorescence microscopy of 
transfected cells 48 h and 72 h post-transfection. “C+” stands for cells transfected with 
empty plasmid (max. excitation/emission at 557/592 nm) and “T” for cells transfected 
with fused DsRed-G6PDH (558/583 nm). (B) Western blot analysis of G6PDH 
expression. “C” stands for the control (non-transfected), “C+” for cells transfected with 
empty plasmid, and “T” for cells transfected with G6PDH. G6PDH, 6PGDH and total 
(G6PDH + 6PGDH) activities in: (C) PYC expressing (293-F5) at 48 h post-transfection 
and (D) at 72 h post-transfection, (E) in parental cells (293-D9) cells at 48 h post-
transfection and (F) at 72 h post-transfection. Transfections were all performed at 67 h. 
Experiments were done in triplicates and error bars are standard error of the mean (SEM). 
U is defined as the amount of enzyme that will catalyze the conversion of 1 µmol of 
substrate per minute. 
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Both cell lines show fluorescence 48 h and 72 h post-transfection (Figure 1 A), in cells either 
transfected with empty plasmid or G6PDH. Plasmid integration was even confirmed 24 h post-
transfection, with a slight fluorescence partly due to the slow maturation of the DsRed protein 
[35,36], and was maintained until the end of the culture (166 h). G6PDH expression was specifically 
assessed by western blot (Figure 1 B), with a clear confirmation of the fused G6PDH-DsRed protein 
at 75 kDa in all transfected batches, for both cell lines. Natural monomeric and dimeric G6PDH 
appear at 50 and 100 kDa respectively. Since G6PDH may be expressed without being active, its 
activity was quantified (Figure 1 C-F). Firstly, 48 h post-transfection, both F5 and D9 cells 
transfected with G6PDH exhibited an enhanced activity level of the enzyme compared to non-
transfected cells (735 and 252% for the F5 and D9 clones, respectively). The differences between 
clones may be explained by the fact that they have not the same growth behavior and so are not at the 
same phase and state at that time of transfection; although the D9 cells were at stationary phase one 
day post-transfection while the F5 cells were still at late exponential phase, hence affecting plasmid 
uptake and transduction processes. 6PGDH activity was also assessed at the same time, and G6PDH 
overexpression did not appear to affect the activity of the second enzyme of the PPP in neither cell 
lines. Activities of the cells transfected with the empty plasmid were not significantly different to 
that of the control. Interestingly, G6PDH activity level remained higher than the control later in the 
culture, as measured 72 h post-transfection (280 and 248% for the F5 and D9 clones, respectively). 
The decrease of G6PDH activity in the F5 clone between 48 and 72 h post-transfection could be 
attributed to a clonal effect from the PYC-modified metabolism. The overall activities showed to 
decrease 72 h post-transfection, which is probably due to a reduced cell metabolism at the plateau 
phase. Interestingly, enzymes activities, even for the controls, are lower in the parental line than in 
the PYC cells, while it has been reported that the flux through PPP was reduced in the PYC cells, but 
in a 13C MFA study conducted using a different media formulation and semi- continuous cultures 
[4]. Indeed, in our study, activities are not measured at the same cell density nor with fresh media 
addition. However, enzyme activities are not necessarily representative of the fluxes, as it has 
already been reported that a 15-fold increase in G6PDH resulted in no significant flux improvement 
via PPP in E. coli [37]. Our results indicate that G6PDH was overexpressed and its activity 
significantly enhanced in the transfected cultures, with a large fraction of the cells transfected 
confirmed by the DsRed fluorescence, as already demonstrated by Gupte et al. [30] also in HEK 293 
(clone T17) cells for the same plasmidic system. 
3.2. G6PDH overexpression has no impact on both growth and nutrient consumption nor on 
interferon production 
The parental and PYC clones were cultured in batch and transfected either with the empty 
plasmid or the plasmid coding for G6PDH at the end of exponential growth (F5 clone) and early 
plateau phase (D9 clone). Non-transfected cells of each clone served as a true control and cells 
transfected with the empty plasmid served as a control in regards of the transfection effect. No 
significant difference attributable to G6PDH overexpression or transfection was observed regarding 
maximal cell density or growth rate for the two clones (Figure 2).  
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Figure 2. Effect of G6PDH overexpression on HEK-293 cell behavior in shake flask 
culture. (A) Viable cell concentration, (B) glucose and (C) glutamine culture medium 
concentration, (D) cell viability, (E) lactate, (F) ammonia and (G) recombinant interferon 
titer concentration, during batch cultivation in shake flasks of parental (293-D9) (: 
Control, : Empty plasmid, : G6PDH) and PYC expressing (293-F5) (: Control,: 
Empty plasmid, : G6PDH) cells. Transfections were all performed at 67 h. 
Experiments were done in triplicates and error bars are standard error of the mean (SEM). 
However, a slight transfection effect with lower viable cell densities during the growth phase 
(67–145 h) and an extended cell viability (0% at 213 vs. 238 h for the PYC cells) can be observed for 
the cells transfected with the empty plasmid and the cells transfected with G6PDH, compared to the 
control. Glucose and glutamine uptake show slower rates, as well as for lactate to a lesser extent, 
following transfection (Figure 2). There was, therefore, no significant specific effect of G6PDH 
overexpression. The 293-F5 clone reached a maximum cell concentration of ~6 × 106 cells/mL 
compared to ~2.5 × 106 cells/mL for the parental. These maximum cell densities are similar to those 
reported by Vallée et al. [10] for the same clones. As reported previously [4], the cell density 
increase of the PYC clone compared to the parental one is due to a prolonged exponential phase with 
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growth rates of 0.036 and 0.035 h−1 for the PYC and the D9 clones respectively. Thereafter, cultures 
of transfected cells lasted one day more than the control, but it is most likely due to nutrients 
depletion and not to G6PDH overexpression, since this phenomenon was also observed for cells 
transfected with empty plasmid. Apart from the slight differences mentioned above and attributed to 
a transfection effect, the two clones behaved similarly, as described previously [4,10]. The PYC cell 
line shows a more efficient metabolism in batch mode with a lower lactate production (13 vs 19 mM 
at 67 h for the F5 and D9 clones, respectively), although reaching higher maximum cell 
concentration, and a shift in lactate consumption at the mid-late exponential phase. Concomitant to a 
reduction of lactate production and of glutamine consumption for the F5 clone, less ammonia was 
produced (Figure 2), phenomena which favor cell growth [38].  
Similarly to cell growth behavior, the maximal interferon titer was not significantly affected by 
the transfection process, although both clones transfected with empty plasmid or G6PDH exhibit a 
slower production rate (4.4 vs 3.7 and 8.2 vs 7.6 µg/106 cells/d, for the F5 and the D9, respectively) 
(Figure 2). This result suggests that the synthesis of the fluorescent protein alone or of the fused 
G6PDH-DsRed might, together with the transfection conditions, be at the expense of growth and 
protein production. A slight decrease is observed at 115 h and 166 h for parental cells and PYC 
expressing cells respectively, i.e. culture times corresponding to the decrease of cell viability for both 
cell lines. Parental cells yielded a maximum interferon concentration of 140 mg/mL whereas the 
PYC clone reached 110 mg/mL. It is often reported in literature that high producing clones present a 
more efficient lactate metabolism [15,33,39]. Even if the PYC clone seems to be metabolically more 
efficient, this has not been translated into an improved production in interferon compared to the D9 
clone, suggesting that the ameliorations gained in term of growth are detrimental to interferon 
production in batch mode. 
3.3. PPP is highly regulated: G6PDH overexpression has no effective long-term effect on the cells 
metabolic behavior 
Concomitant to the results on cell growth and interferon production, and apart for some 
epiphenomena, no significant effect due to G6PDH overexpression was observed at the metabolic 
level. It was expected that G6PDH overexpression would enhance NADPH production rate, and thus 
modifies the PPP dynamics such as for the trends of the NADPH-to-NADP+ratio. Comparing 
average values one day post-transfection, transfected cells exhibit lower levels of NADPH and 
NADP+ (Figure 3), but the G6PDH transfected cells seem to compensate for the transfection effect, 
as shown from results for the empty plasmid.  
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Figure 3. Effect of G6PDH overexpression on HEK-293 cell energetic and redox status. 
(A) NADH-to-NAD+ ratio, (B) NADPH-to-NADP+ ratio, (C) ATP-to-ADP ratio, (D) 
ATP-to- AMP ratio, and (E) UDPG, (F) AMP, (G) NADH, (H) NADP+, (I) NADPH, (J) 
ADP, (K) CTP, (L) GTP, (M) ATP, (N) UTP and (O) NAD+ cell concentration profiles 
during batch cultivation in shake flasks of parental (293-D9) (: Control, : Empty 
plasmid, : G6PDH) and PYC expressing (293-F5) (: Control,: Empty plasmid, : 
G6PDH) cells. Transfections were all performed at 67 h. Experiments were done in 
triplicates and error bars are standard error of the mean (SEM). 
More interestingly, there is no significant effect of transfection on the NADPH-to-NADP+ ratio 
with empty plasmid or G6PDH, and it stays interestingly constant for both cell lines and at a similar 
value, except for the transfected D9 cells with empty plasmid; although this difference is not 
significant when considering error bars. Templeton et al. [40] observed a drop of the NADPH-to-
NADP+ ratio at peak flux through PPP in fed-batch culture of CHO cells, while no such drop was 
observed in our work, even in the control cultures. The stability of the ratio indicates a strong 
robustness of the cells metabolism. The fact that 6PGDH activity is not affected by G6PDH 
overexpression, together with stable intracellular metabolites and nucleotides pools (Figure 3,4) are 
supporting this hypothesis. At first sight, it can be hypothesized that the overall NADPH production, 
including from other sources than G6PDH, is regulated and compensated. Henry and Durocher [4] 
reported that malic enzyme compensated a loss in NADPH production due to lesser fluxes to PPP in 
PYC cells. Indeed, Pollack et al. [41] showed that NAD kinase, producing NADP+ from NAD+, is an 
efficient enzyme candidate to enhance NADPH pool, but it also provides only a moderate protection 
increase against oxidative stress. Re-reducing NADP+ into NADPH by the various dehydrogenases 
may be a favored mechanism to maintain NADPH level in HEK293 cells. Interestingly, in their 
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study, overexpression of NADK did not affect mRNA levels of G6PDH, 6PGL or 6PGDH, so no 
increase in the activities of the overall reducers of NADP+ was observed, thus accounting that their 
activities are sufficient to reduce the excess of NADP+. Of interest, cells lacking NADK may only 
show a slight increase of associated mRNA levels, and thus account for cell robustness. The 
hypothesis of refueling NADPH by re-reducing NADP+ is thus consistent with the constant ratio 
obtained in this study. The level of G6P, the entry point of PPP, seems slightly higher in both cell 
lines until 142 h when transfected with G6PDH (Figure 4). Oppositely to what could have been 
expected, G6PDH overexpression did not lead to a decreased pool of G6P. This suggests that the 
reaction is repressed even in the presence of large quantities of the active enzyme, as previously 
reported by Nicolas et al. [37]. D9 cells exhibit higher levels of G6P, glycerol-3-phosphate and 
GA3P & DHAP than the F5 cells, a result that can mostly be attributed to the pull effect toward the 
TCA cycle for PYC cells. The levels of GA3P & DHAP and glycerol-3-phosphate in the G6PDH 
transfected D9 cells are clearly higher (Figure 4), indicating an accumulation phenomenon, probably 
via PPP. Indeed, GA3P & DHAP are the point of return of PPP in the glycolysis. 
 
Figure 4. Effect of G6PDH overexpression on HEK-293 cells central metabolism. (A) 
pyruvate, (B) malate, (C) glycerol-3-phosphate, (D) succinate, (E) glucose-6-phosphate, 
(F) GA3P & DHAP, (G) fumarate and (H) -ketoglutarate cell concentration profiles 
during batch cultivation in shake flasks of parental (293-D9) (: Control, : Empty 
plasmid, : G6PDH) and PYC expressing (293-F5) (: Control,: Empty plasmid, : 
G6PDH) cells. Transfections were all performed at 67 h. Experiments were done in 
triplicates and error bars are standard error of the mean (SEM). 
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3.4. The PYC gene expression has a strong effect on the cells energetic and redox states, but not the 
G6PDH 
As shown earlier, G6PDH overexpression has no impact on the overall NADPH-to-NADP+ ratio, 
and the same observation can be noted for the other energetic and redox compounds, apart from 
some epiphenomena attributed to transfection effect. One day post-transfection, ATP-to-ADP and 
ATP-to-AMP ratios increased in the transfected F5 cells, and NADH-to-NAD+ ratio decreased in 
both cell lines, observations attributed to the lower levels of ADP and AMP in the F5 cells and lower 
NADH, NAD+ levels in the two cell lines (Figure 3). Surprisingly, the ATP-to-ADP, ATP-to-AMP 
and NADH-to-NAD+ ratios are lower for the PYC clone than for the parental. The ATP-to-AMP 
ratio is more sensitive to changes of the cell energetic state [42], and is thus suggesting an 
unfavorable energetic state in the PYC cells. Moreover, the cell concentrations in NAD+ and NADH 
are also lower for the PYC clone compared to the parental. However, no elevation of the ATP pool 
was observed in the PYC cells, a behavior which has been reported for PYC expressing BHK cells; 
since high intracellular ATP level is normally interpreted as a higher energetic efficiency [43]. 
However, higher ADP levels in the F5 cells may be due to a higher ATP utilization rate. Lower 
energetic and redox ratios may indicate increased metabolic rates, or at least a higher and sustained 
energetic demand. A lower NADH-to-NAD+ ratio favors TCA cycle activity and the conversion of 
lactate to pyruvate, and lower NAD+ in the PYC cells is consistent with its use in those reactions. 
Indeed, lower concentration in electron carriers such as NADH can partly explain the lower 
interferon production level of the transfected PYC cells, since it has been reported by Chong et al. 
[44] for CHO cells that high producer cell lines exhibit higher levels of those molecules. Normally, 
the conversion of lactate to pyruvate and high flux rates through TCA cycle [4] should result in 
increased NADH levels in PYC cells, and even in increased NADPH via increased H+ gradients 
through mitochondrial membrane [45]. An increased NADH-to-NAD+ ratio in PYC CHO cells was 
observed by Wilkens and Gerdtzen [46], oppositely to the results reported in this work, showing that 
increased NADH-to-NAD+ levels are consistent with low lactate synthesis. However, our results are 
consistent with increased pyruvate recycling via malic enzyme as observed by Henry and Durocher 
[4], hence consuming NADH. Interestingly, redox ratio drops simultaneously to TCA intermediates 
concentration (Figure 3,4). Contrary to what is usually reported [45,47], NADH-to-NAD+ ratios are 
higher than NADPH-to-NADP+ ratios in our study, maybe indicating that the overall NADPH 
production is insufficient in both cell lines. The PYC cells also exhibit lower levels of glycerol-3-
phosphate (Gly3P) and DHAP (Figure 4). Glycerol phosphate shuttle (Gly3P, DHAP) main function 
is to re-oxidize cytosolic NADH and reduce FAD in the mitochondria, hence sustaining ATP 
production and NAD+ recycling. The low levels of Gly3P and DHAP in the F5 cell line indicate that 
this shuttle is probably not efficient enough, thus explaining the lower levels of NAD+ and ATP. It 
could be hypothesized that the prolonged exponential phase of the PYC cells requires a higher de 
novo synthesis of nucleotides [48]. Moreover, the importance of G6PDH in cell growth [22] as well 
as for providing R5P for nucleic acids synthesis [24] has been characterized, but no long term 
significant change was observed due to G6PDH in the nucleotides pools. F5 cells exhibit similar 
levels of CTP and UTP than in parental cells, but lower levels of GTP and higher levels of UDPG 
(Figure 3). It should be noted that G6PDH transfected D9 cells seem to compensate for the 
transfection effect in CTP and GTP at 115 h and even enhance UTP and UDPG at this time point 
(Figure 3), maybe due to an increased synthesis of precursors via PPP. Accumulation of GTP in D9 
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cells can be attributed to early cell growth arrest. Chong et al. [44] reported that high producers have 
more nucleotide-activated sugar precursors, such as UDPG, a precursor of N-glycans or glycolipids 
for plasmic membrane synthesis. UDPG high level in the PYC cells can thus be attributed to 
supporting cell growth and protein glycosylation processes. 
3.5. TCA cycle activity is neither affected by G6PDH overexpression 
None of the TCA metabolites assessed in this study were significantly affected by G6PDH 
overexpression, nor transfection (Figure 4). F5 (PYC) cells exhibit lower levels of pyruvate, 
glycerol-3-phosphate and GA3P & DHAP than the parental cells, accounting for the pull effect of the 
PYC toward TCA cycle. This is consistent with Luo et al. [49] where metabolites measured in the 
TCA and glycerol-3-phosphate were lower in CHO cells exhibiting a switch to lactate consumption. 
Pyruvate level decreases in both cell lines, but to a lesser extent in the D9 clone. Lactate 
consumption may fuel pyruvate levels in the PYC clone, and lactate production has already been 
linked to pyruvate accumulation in the cells [47]. Oppositely, D9 cells show lower levels of malate, 
succinate, fumarate and alpha-ketoglutarate. Interestingly, the levels of these metabolites drop in the 
F5 cells after 95 h, when entering late exponential growth phase, accordingly with the beginning of 
lactate consumption, suggesting a metabolic switch through TCA cycle. However, it seems that the 
PYC cells show lower concentrations in those molecules, as well as in pyruvate at the end of the 
culture. Extracellular amino acids concentrations behavior agrees with observations on central 
carbon metabolites. Concentrations of threonine, isoleucine, leucine, methionine, valine, tyrosine, 
serine, arginine, lysine and phenylalanine exhibit very similar trends (Figure 5) with decreasing 
levels and a plateau beginning at 115 h or 145 h.  
The two cell lines show similar behavior except that PYC cells consume less amino acids per 
106 cells with the exception of asparagine, lysine and histidine, and reach lower levels than those 
observed for the parental cells. They also produce less proline and more alanine, glycine and 
glutamate. However, Henry and Durocher [4] reported increased utilization of threonine, arginine, 
valine, isoleucine, leucine, lysine, phenylalanine, as well as lower glutamate and asparagine 
production by the PYC cells, while reaching a lower cell density cultured in a different medium 
formulation. The PYC cells showed depletion of serine and arginine earlier than for D9 cells, before 
entering the stationary phase. This result suggests these amino acids are essential growth-limiting 
nutrients. Asparagine is consumed in both cell lines, but at a higher extent by the PYC cell line. High 
asparagine consumption has been likely linked to replenishment of TCA cycle intermediates [50,51]. 
Indeed, most of these amino acids are precursors or products closely issued from the TCA cycle. It is 
also expected that with an extended exponential phase, PYC cells consume nutrients for a longer 
time to support prolonged cell growth. Proline is clearly produced during the culture of both cell 
lines, but it is more accumulated in the extracellular media of D9 cells (Figure 5). It can be 
synthesized from glutamate, and the higher level of proline for the D9 cells are concomitant with the 
lower glutamate level. Alanine level is more fluctuating but globally reaches higher levels in the 
PYC cells at the end of the culture. Alanine can be synthetized from pyruvate and other amino acids 
such as isoleucine, leucine and valine. Therefore, alanine concentration fluctuation can be related to 
an equilibrium with pyruvate. Aspartic acid, a precursor of pyrimidines used in nucleotides synthesis, 
is used equally in the two cells lines most probably to feed nucleotides synthesis and cell growth. 
Histidine level is quite constant over the whole culture of D9 cells, while it decreases in the PYC 
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cells, reaching a lower level at the end of the culture, maybe to supply alpha-ketoglutarate to the 
TCA.  
 
Figure 5. Effect of G6PDH overexpression on HEK-293 cells amino acids metabolism. 
(A) threonine, (B) isoleucine, (C) leucine, (D) methionine, (E) tyrosine, (F) valinine, (G) 
proline, (H) alanine, (I) glycine, (J) serine, (K) glutamate, (L) asparagine, (M) aspartate, 
(N) arginine, (O) lysine, (P) histidine (Q) phenylalanine culture medium concentration 
profiles, and (R) global amino acids consumption/production during batch cultivation in 
shake flasks of parental (293-D9) (: Control, : Empty plasmid, : G6PDH) and 
PYC expressing (293-F5) (: Control,: Empty plasmid, : G6PDH) cells. 
Transfections were all performed at 67 h. Experiments were done in triplicates and error 
bars are standard error of the mean (SEM). 
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As seen previously for glucose and glutamine, a slight transfection effect can be observed on 
amino acids uptake, but can hardly be attributed to G6PDH overexpression. Thus, G6PDH did not 
impact on metabolites concentration in none of the cell lines, but given the modified metabolism of 
the PYC cell line, the two cell lines exhibit highly different metabolic profiles. The present results on 
cell management of external nutrients and metabolites globally agree with that of a previous 13C 
MFA study performed with the same HEK293 D9 and PYC cell lines [4]. However, our G6PDH 
activity level measurements clearly support the hypothesis of a tight regulation of the PPP, since 
G6PDH activity level differences among cell lines in this work do not agree with the differences 
reported for the PPP flux rates determined in a 13C MFA study [4]. Similar comparison based on a 
13C MFA study can be drawn for CHO cells [13]. 
4. Conclusion 
In this work, we have transiently transfected two filiated HEK 293 clones with G6PDH in an 
attempt to bypass the highly regulated glycolysis and increase NADPH and precursors production for 
both protein production and cell growth. The PYC cell line was expected to amplify and benefit from 
the effect of G6PDH overexpression because of the “pull” effect of PYC from glycolysis 
downstream toward the TCA cycle. Some epiphenomena can be observed, mostly one day post-
transfection, where levels of metabolites for the transfected cells do not follow the same trends as for 
the control. The results show that both cell lines, parental and the F5 clone, are highly robust towards 
transient G6PDH overexpression, showing little change in terms of protein production, cell growth 
and metabolites concentration. In complement, similar transient experiments have been performed on 
IgG producing CHO cells in 6-well plates and shake-flasks (not shown data). However, no effect was 
observed on antibody titer nor cell growth, even for overexpressed and over-activated G6PDH, 
similarly as reported in the HEK 293 cell lines studied in this work. This also indicates that pentose 
phosphate pathway regulation should be reviewed and further implemented. This work thus exposes 
global metabolic signatures of the two cell lines, submitted or not to transient G6PDH 
overexpression, thus providing novel data on cell energetics, redox states and metabolites 
concentration. However, results may differ with cell lines stably overexpressing G6PDH. 
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